Carnitine metabolites and cognitive improvement in patients with schizophrenia treated with olanzapine: a prospective longitudinal study

Objective: Cognitive impairment is one of the core symptoms of schizophrenia, which is stable and lifelong. L-carnitine has been shown to improve cognitive function and decrease the rate of cognitive deterioration in patients with Alzheimer's disease. However, it remains unclear regarding the r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lei Zhao (Autor), Hua Liu (Autor), Wenjuan Wang (Autor), Youping Wang (Autor), Meihong Xiu (Autor), Shuyun Li (Autor)
Format: Llibre
Publicat: Frontiers Media S.A., 2023-08-01T00:00:00Z.
Matèries:
Accés en línia:Connect to this object online.
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

Connect to this object online.

3rd Floor Main Library

Detall dels fons de 3rd Floor Main Library
Signatura: A1234.567
Còpia 1 Disponible